Characteristics, biokinetics, and biological effects of depleted uranium used in weapons and the french nuclear industry

Depleted Uranium: Properties, Uses, and Health Consequences

Volumn , Issue , 2006, Pages 21-54

  Chazel, Valérie ^a   Houpert, Pascale ^a   Paquet, François ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056912200     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (53)

1. Durante, M. and Pugliese M., Estimates of radiological risk from depleted uranium weapons in war scenarios, Health Phys., 82, 14, 2002.
2. The Royal Society, The health hazards of depleted uranium munitions part I. Policy document 6/01, London, 2001. Online report available at www.royalsoc.ac.uk in the science policy section.
3. Hanson, W.C., et al., Particle Size Distribution of Fragments from Depleted Uranium Penetrators Fired against Armor Plate Targets, Report LA-5654, Los Alamos Scientific Laboratory, Los Alamos, 1974.
4. Patrick, M.A. and Cornette, J.C., Morphological Characteristics of Particulate Material Formed from High Velocity Impact of Depleted Uranium Projectiles with Armor Targets, Report AFATL-TR-78-117, Air Force Armament Laboratory, November 1978.
5. Parkhurst, M.A., et al., Depleted Uranium Aerosol Doses and Risks: Summary of US Assessments, Report PNWD-3476, prepared for the U.S. Army by Battelle, 2004.
6. Glissmeyer, J.A. and Mishima, J., Characterization of Airborne Uranium from Test Firings of XM774 Ammunition, Report PNL-2944, Pacific Northwest Laboratory, Richland, WA, 1979.
7. Chambers, D.R., et al., Aerosolization Characteristics of Hard Impact Testing of Depleted Uranium Penetrators, Technical Report ARBRL-TR-023435, Aberdeen Proving Ground, MD: Ballistic Research Laboratory, October 1982.
8. Brown, R., Depleted Uranium Munitions and Assessment of the Potential Hazards. Notes of a presentation to the Royal Society Working Group on January 19, 2000.
9. Scripsick, R.C., et al., Preliminary study of uranium oxide dissolution in simulated lung fluid, Report LA-10268-MS, Los Alamos National Laboratory, 1985. http://lib-www.lanl.gov/la-pubs/00318819.pdf.
10. Scripsick, R.C., et al., Differences in in vitro dissolution properties of settled and airborne uranium material, in Occupational Radiation Safety in Mining, Stocker, H., Ed., Canadian Nuclear Association 255, 1985. http://lib-www.lanl.gov/la-pubs/00374828.pdf.
11. Depleted Uranium in Kosovo, post conflict environmental assessment, UNEP, 157-162, 2001.
12. Larousserie, D., Enquête sur l’U.A, Sciences et Avenir, p. 105, décembre 2000.
13. Chazel, V., et al., Characterisation and dissolution of depleted uranium aerosols produced during impacts of kinetic energy penetrators against a tank. Radiat. Prot. Dosimetry, 105, n° 1-4, 2003.
14. Jarvis, N.S. and Birchall, A., Ludep 2.0. Personal computer program for calculating internal doses using ICRP publication 66 respiratory tract model, NRPB-SR287, 1996.
15. Miller, A., Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy metal-tungsten alloy particles: induction of genotoxic effects, Carcinogenesis, 22(1), 115, 2001.
16. 8 specific surface area on in vitro dissolution, biokinetics and dose coefficients, Radiat. Prot. Dosimetry, 79, 39, 1998.
17. Chazel, V., et al. Variation of solubility, biokinetics and dose coefficient of industrial uranium oxides according to specific surface area, Radiat. Prot. Dosimetry, 88, 223, 2000.
18. ICRP, Dose coefficients for intakes of radionuclides by workers, ICRP Publication 68, Annals of the ICRP 24(4), Elsevier Science Ltd., Oxford, 1994.
19. UNSCEAR, Sources and Effects of Ionizing Radiation, Report to the General Assembly, with Annexes (New York: United Nations), 1977.
20. Ansoborlo, E., et al., Determination of the physical and chemical properties, biokinetics and dose coefficients of uranium compounds handled during nuclear fuel fabrication in France, Health Phys., 82, 279, 2002.
21. Monleau, M., et al., The effect of repeated inhalation on the distribution of uranium in rats, JTHE, in press.
22. ICRP, Limits for intakes of radionuclides by workers, ICRP Publication 30, Part 1, Annals of the ICRP 2(3/4), Pergamon Press, Oxford, 1979.
23. ICRP, Age-dependent doses to members of the public from intake of radionuclides: Part 4 Inhalation dose coefficients, ICRP Publication 71, Annals of the ICRP 25(3-4), Elsevier Science Ltd., Oxford, 1995.
24. Birchall, A., and James, A.C., A general algorithm for solving compartmental models with constant coefficients and its implementation on a microcomputer, NRPB-R216, 1987.
25. Guglielmotti, M.B., et al., Effects of acute intoxication with uranyl nitrate on bone formation, Experientia, 40, 474, 1984.
26. Diaz Sylvester, P.L., et al., Exposure to subcutaneously implanted uranium dioxide impairs bone formation, Arch. Environ. Health, 57, 320, 2002.
27. Ubios, A.M., et al., Uranium inhibits bone formation in physiologic alveolar bone modeling and remodeling, Environ. Res., 54, 17, 1991.
28. Paquet, F., et al., Accumulation and distribution of uranium in rats after chronic exposure by ingestion, Health Phys. 90, 139, 2006.
29. Monleau, M., et al., Distribution and genotoxic effects after successive exposures to different uranium oxides particles inhaled by rats, Inhalation Toxicol., in revision, 2006.
30. Benson, J.M., et al., Effects of Repeated Inhalation Exposure of F344 Rats and B6C3F1 Mice to Nickel Oxide and Nickel Sulphate Hexahydrate on Lung Clearance, LRRI report, Albuquerque, NM, 1992.
31. Benson, J.M., et al., Particles clearance and histopathology in lungs of F344/N rats and B6C3F1 mice inhaling nickel oxide or nickel sulfate. Fundam. Appl. Toxicol., 28, 232, 1995.
32. Fulco, C.E., Liverman, C.T., and Sox, H.C., Depleted uranium, in Fulco, C.E., Liverman, C.T., and Sox, H.C., Eds., Gulf War and Health, Vol. 1, Depleted uranium, Pyridostigmine bromide, Sarin and Vaccines, National Academies Press, Washington, DC, 2000, pp. 89-168.
33. Durakovic, A., Medical effects of internal contamination with uranium, Croat. Med. J., 42, 49, 1999.
34. Durakovic, A., et al., Estimate of time zero lung burden of depleted uranium in Persian Gulf War veterans by the 24-hours urinary excretion and exponential decay analysis, Mil. Med., 168, 600, 2003.
35. Salbu, B., et al., Oxidation states of uranium in depleted uranium particles from Kuwait, J. Environ. Radioact., 78, 125, 2005.
36. Monleau, M., et al., Bioaccumulation and behavioural effects of depleted uranium in rats exposed to repeated inhalations, Neuro. Lett., 390, 31, 2005.
37. Tjalve, H., et al., Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats, Pharmacol. Toxicol., 79, 347, 1996.
38. Henriksson, J., Tallkvist, H., and Tjalve, H., Uptake of nickel into the brain via olfactory neurons in rats, Toxicol. Lett., 91, 153, 1997.
39. Henriksson, J., and Tjalve, H., Uptake of inorganic mercury in the olfactory bulbs via olfactory pathways in rats, Environ. Res., 77, 130, 1998.
40. Persson, E., et al., Transport and subcellular distribution of intranasally administered zinc in the olfactory system of rats and pikes, Toxicology, 191, 97, 2003.
41. Persson, E., Henriksson, J., and Tjalve, H., Uptake of cobalt from the nasal mucosa into the brain via olfactory pathways in rats, Toxicol. Lett., 145, 19, 2003.
42. Rao, D.B., et al., Inhaled iron, unlike manganese is not transported to the rat brain via the olfactory pathway, Toxicol. Appl. Pharmacol., 193, 116, 2003.
43. Dorman, D.C., et al., Influence of particle solubility on the delivery of inhaled manganese to the rat brain: manganese sulfate and manganese tetroxide pharmacokinetics following repeated (14-d) exposure, Toxicol. Appl. Pharmacol., 170, 79, 2001.
44. Pellmar, T.C., et al., Distribution of uranium in rats implanted with depleted uranium pellets, Toxicol. Sci., 49, 29, 1999.
45. Pellmar, T.C., et al., Electrophysiological changes in hippocampal slices isolated from rats embedded with depleted uranium fragments, Neurotoxicology, 20, 785, 1999.
46. Barber, D.S., Ehrich, M.F., and Jortner, B.S., The effect of stress on the temporal and regional distribution of uranium in rat brain after acute uranyl acetate exposure, J. Toxicol. Environ. Health, 68, 99, 2005.
47. Houpert, P., et al., Enriched uranium but not depleted uranium affects central nervous system in long-term exposed rat, Neurotoxicology, 26, 1045, 2006.
48. ATSDR, Toxicological Profile for Uranium, Public health service, agency for toxic substances and disease registry, U.S. Department of health and human services, Atlanta, GA, 1999.
49. Miller, A., Potential late health effects of depleted uranium and tungsten used in armor-piercing munitions: comparison of neoplastic transformation and genotoxicity with the known carcinogenic nickel, Mil. Med., 167, 120, 2002.
50. Miller, A., et al., Genomic instability in human osteoblast cells after exposure to depleted uranium: delayed lethality and micronuclei formation, J. Environ. Radioact., 64, 247, 2003.
51. Monleau, et al., Genotoxic and inflammatory effects of depleted uranium particles inhaled by rats, Toxicol. Sci., 89, 287, 2006.
52. Gazin, V., et al., Uranium induces TNF alpha secretion and MAPK activation in a rat alveolar macrophage cell line, Toxicol. Appl. Pharmacol. 194, 49, 2004.
53. Taylor, M.D., et al., Effects of welding fumes of differing composition and solubility on free radical production and acute lung injury and inflammation in rats, Toxicol. Sci., 75, 181, 2003.